PIPages
Labs

Madhumathi Rao

University of Kentucky, KY·Medicine & Clinical Research

Osteoporosis, the thinning of bone that leads to fractures, affects more than 40 million Americans. It causes more hospital admissions than heart attacks, strokes and breast cancer combined.

Fields

Medicine & Clinical Research

Physiology

Topics

osteoporosis

age-related bone loss

bone turnover

Grants
1 known grant, last ended Aug 2026

What they work on

  1. Test whether women with low-turnover, age-related osteoporosis gain more bone mineral density over one year on teriparatide, a bone-building drug, than on standard alendronate, using a randomized comparison and DXA bone scans.
  2. Determine whether blood levels of carboxylated osteocalcin (1-43/49), a bone-derived protein, alone or combined with other bone markers, can diagnose low bone turnover, validated against bone biopsy and histomorphometry.
  3. Classify osteoporotic women by bone turnover status using biopsy histomorphometry, including a normal-to-high-turnover group treated with alendronate as a comparison for the blood-based test.

More about the research

Yet it is not one disease. Bone loss after menopause, driven by low estrogen, involves high "bone turnover": bone is broken down faster than it is rebuilt. Age-related bone loss, which can begin in a person's 40s, usually involves low turnover, where the main problem is that too little new bone is made. Standard care starts most patients on an antiresorptive drug, which slows bone breakdown. This may work poorly for low-turnover patients and may even blunt later bone-building drugs. Doctors rarely tell the two types apart because measuring turnover requires a bone biopsy.

Why it matters

About a quarter of women over 65 have osteoporosis, and fractures place a heavy burden on older adults and the health system. If low-turnover, age-related osteoporosis responds better to bone-building drugs first, and if a simple blood test can identify it without a bone biopsy, doctors could match treatment to each patient's type of bone loss and may prevent more fractures.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Novel precision medicine approach to treatment of osteoporosis based on bone turnover

NIH · Sep 2021 – Aug 2026

Closest labs

Sabrina Noel

University of Massachusetts-Lowell, MA·Public Health & Epidemiology

Test whether tailored nutrition education with complementary food provision reduces food insecurity and improves diet, blood glucose and HIV outcomes, in a randomized pilot trial of 100 people with HIV and prediabetes.

Carol Everson

Medical College of Wisconsin, WI·Physiology

Test whether chronic sleep restriction after skeletal maturity impairs bone remodeling and increases fragility, by sleep-restricting male and female rats for 10 weeks and measuring bone strength, structure and cellular features.

John Fowlkes

University of Kentucky, KY·Physiology

Determine how deficiencies of insulin and insulin-like growth factor 1 (IGF-1) each contribute to diabetic bone disease at the tissue, cellular and molecular levels in models of type 1 diabetes.

The school

University of Kentucky: 34 labs on PI Pages, $528M a year on research, 319 research doctorates a year.

More about University of Kentucky

Reach out

A start for your email. Fill in the brackets.